BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin.
Bansal N, Marchion DC, Bicaku E, Xiong Y, Chen N, Stickles XB, Sawah EA, Wenham RM, Apte SM, Gonzalez-Bosquet J, Judson PL, Hakam A, Lancaster JM.
Bansal N, et al. Among authors: wenham rm.
J Gynecol Oncol. 2012 Jan;23(1):35-42. doi: 10.3802/jgo.2012.23.1.35. Epub 2012 Jan 9.
J Gynecol Oncol. 2012.
PMID: 22355465
Free PMC article.